CIK 0001133869
- Non-accelerated filer
- Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 310-358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-13 | Litvack Frank Director | Option exercise | +3,937 | $1.39 | $5K | 133,776 |
| 2026-05-13 | Litvack Frank Director | Option exercise · Stock Option (Right to Buy) | −3,937 | 0 | ||
| 2026-01-05 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-03-03 | Litvack Frank Director | Option exercise | +25,000 | $1.39 | $35K | 132,382 |
| 2025-03-03 | Litvack Frank Director | Shares withheld for taxes | −2,543 | $13.67 | $35K | 129,839 |
| 2025-03-03 | Litvack Frank Director | Option exercise · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-01-02 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-12-03 | Litvack Frank Director | Option exercise | +20,391 | $1.10 | $22K | 46,278 |
| 2024-12-03 | Litvack Frank Director | Option exercise · Warrants (Right to Buy) | −20,391 | 0 | ||
| 2024-12-02 | Litvack Frank Director | Gift · Warrants (Right to Buy) | −20,391 | 0 | ||
| 2024-12-02 | Litvack Frank Director | Gift · Warrants (Right to Buy) | +20,391 | 20,391 | ||
| 2024-01-02 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2023-08-14 | Litvack Frank Director | Option exercise | +20,748 | $1.39 | $29K | 137,633 |
| 2023-08-14 | Litvack Frank Director | Shares withheld for taxes | −4,364 | $6.61 | $29K | 133,269 |
| 2023-08-14 | Litvack Frank Director | Option exercise · Stock Option (Right to Buy) | −20,748 | 0 | ||
| 2023-02-21 | Litvack Frank Director | Option exercise | +14,027 | $1.39 | $19K | 141,800 |
| 2023-02-21 | Litvack Frank Director | Shares withheld for taxes | −4,524 | $4.31 | $19K | 137,276 |
| 2023-02-21 | Litvack Frank Director | Option exercise · Stock Option (Right to Buy) | −14,027 | 0 | ||
| 2023-01-03 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +185,000 | 185,000 | ||
| 2022-01-03 | Litvack Frank Director | Option exercise | +154,543 | $1.39 | $215K | 174,934 |
Page 1 of 3 · 51 trades